Listen for Dental Problems With Buccal or Sublingual Buprenorphine
March 2022
A new FDA warning will spur questions about the risk of dental problems with buccal or sublingual buprenorphine (Suboxone, etc).
Labels will now caution about cavities, tooth loss, and other oral health issues. These can happen even in patients withOUT a history of dental problems.
It may be because these products create an acidic environment in the mouth...which can wear away tooth enamel and lead to decay within weeks or years.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote